Corticosteroids in the Management of Pregnant Patients With Coronavirus Disease (COVID-19).
Obstet Gynecol
; 136(4): 823-826, 2020 10.
Article
in English
| MEDLINE | ID: covidwho-706939
ABSTRACT
Recent evidence supports the use of an early, short course of glucocorticoids in patients with COVID-19 who require mechanical ventilation or oxygen support. As the number of coronavirus disease 2019 (COVID-19) cases continues to increase, the number of pregnant women with the disease is very likely to increase as well. Because pregnant women are at increased risk for hospitalization, intensive care unit admission, and mechanical ventilation support, obstetricians will be facing the dilemma of initiating maternal corticosteroid therapy while weighing its potential adverse effects on the fetus (or neonate if the patient is postpartum and breastfeeding). Our objective is to summarize the current evidence supporting steroid therapy in the management of patients with acute respiratory distress syndrome and COVID-19 and to elaborate on key modifications for the pregnant patient.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Pregnancy Complications, Infectious
/
Coronavirus Infections
/
Critical Care
/
Medication Therapy Management
/
Pandemics
/
Glucocorticoids
Type of study:
Observational study
/
Prognostic study
Limits:
Female
/
Humans
/
Infant, Newborn
/
Pregnancy
Language:
English
Journal:
Obstet Gynecol
Year:
2020
Document Type:
Article
Affiliation country:
AOG.0000000000004103
Similar
MEDLINE
...
LILACS
LIS